Search abstracts

Optimising human factors within regulatory processes to accelerate safe biopharmaceutical innovation

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: PARSONS, Andrew (Reciprocal Minds Limited)
  • Co-author(s): Andrew Parsons: Reciprocal Minds Limited, Welwyn Garden City, United Kingdom
    Allison Morgan: Metis Clinical, Ascot, United Kingdom
    Simon Whiteley: Whiteley Aerospace Safety Engineering & Management Limited, Swindon, United Kingdom
    Crystal Ruff: Illumina, Cambridge, United Kingdom
    Fiona Day: Beaconbrands , London, United Kingdom
    Julia Mironova: Beaconbrands, London, United Kingdom
    Brian Edwards: NDA Regulatory Science Ltd, Leatherhead, United Kingdom
  • Abstract:


    Human factors (HF) allow optimisation of the interface between people and all aspects of a system. Despite recent technological advances, the basic principles of medicines development have not changed since the ’80 and have been stated to be “broken” [1].


    Using a system engineering model (STAMP) [2] the BP development process was


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses